Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


19.07.2021

1 Am J Epidemiol
16 Ann Surg Oncol
3 BMC Cancer
2 Br J Cancer
1 Breast Cancer
1 Breast Cancer (Auckl)
2 Breast Cancer (Dove Med Press)
1 Breast Cancer Res
9 Breast Cancer Res Treat
2 Cancer
1 Cancer Cell
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
1 Cancer Res
3 Clin Breast Cancer
1 Clin Cancer Res
1 Eur J Cancer
4 Eur Radiol
1 Int J Cancer
2 J Natl Cancer Inst
1 Lancet Oncol
2 N Engl J Med
2 NPJ Breast Cancer
2 Oncogene
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Epidemiol

  1. NIEHOFF NM, O'Brien KM, Keil AP, Levine KE, et al
    Metals and Breast Cancer Risk: A Prospective Study Using Toenail Biomarkers.
    Am J Epidemiol. 2021 Jul 15. pii: 6322281. doi: 10.1093.
    PubMed         Abstract available


    Ann Surg Oncol

  2. WEISER R, Polychronopoulou E, Haque W, Hatch SS, et al
    ASO Visual Abstract: Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases-An NCDB Analysis.
    Ann Surg Oncol. 2021 Jul 14. pii: 10.1245/s10434-021-10419.
    PubMed        

  3. NAFFOUJE SA, Sabesan A, Hoover SJ, Lee MC, et al
    Surgical Management of the Axilla of HER2+ Breast Cancer in the Z1071 Era: A Propensity-Score-Matched Analysis of the NCDB.
    Ann Surg Oncol. 2021 Jul 14. pii: 10.1245/s10434-021-10411.
    PubMed         Abstract available

  4. TONNESON JE, Hoskin TL, Durgan DM, Corbin KS, et al
    Decreasing the Use of Sentinel Lymph Node Surgery in Women Older than 70 Years with Hormone Receptor-Positive Breast Cancer and the Impact on Adjuvant Radiation and Hormonal Therapy.
    Ann Surg Oncol. 2021 Jul 13. pii: 10.1245/s10434-021-10407.
    PubMed         Abstract available

  5. TASKINDOUST M, Thomas SM, Sammons S, Fayanju OM, et al
    ASO Visual Abstract: Survival Outcomes Among Patients with Metastatic Breast Cancer: Review of 47,000 Patients.
    Ann Surg Oncol. 2021 Jul 13. pii: 10.1245/s10434-021-10296.
    PubMed        

  6. WEISER R, Klimberg VS
    ASO Author Reflections: Breast Cancer: What is in a Positive Node?
    Ann Surg Oncol. 2021 Jul 13. pii: 10.1245/s10434-021-10436.
    PubMed        

  7. LIZARRAGA IM, Schroeder MC, Jatoi I, Sugg SL, et al
    Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.
    Ann Surg Oncol. 2021 Jul 12. pii: 10.1245/s10434-021-10426.
    PubMed         Abstract available

  8. WEISER R, Polychronopoulou E, Haque W, Hatch SS, et al
    Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases: An NCDB Analysis.
    Ann Surg Oncol. 2021 Jul 11. pii: 10.1245/s10434-021-10374.
    PubMed         Abstract available

  9. ELMORE LC, Kuerer HM, Barcenas CH, Smith BD, et al
    Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy.
    Ann Surg Oncol. 2021 Jul 10. pii: 10.1245/s10434-021-10444.
    PubMed         Abstract available

  10. OROZCO JIJ, Chang SC, Matsuba C, Ensenyat-Mendez M, et al
    Is the 21-Gene Recurrence Score on Core Needle Biopsy Equivalent to Surgical Specimen in Early-Stage Breast Cancer? A Comparison of Gene Expression Between Paired Core Needle Biopsy and Surgical Specimens.
    Ann Surg Oncol. 2021 Jul 9. pii: 10.1245/s10434-021-10457.
    PubMed         Abstract available

  11. HUYNH V, Colborn K, Smith S, Bonnell LN, et al
    Early Trajectories of Patient Reported Outcomes in Breast Cancer Patients Undergoing Lumpectomy Versus Mastectomy.
    Ann Surg Oncol. 2021 Jul 15. pii: 10.1245/s10434-021-10450.
    PubMed         Abstract available

  12. CORIDDI M, Kim L, McGrath L, Encarnacion E, et al
    Accuracy, Sensitivity, and Specificity of the LLIS and ULL27 in Detecting Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2021 Jul 15. pii: 10.1245/s10434-021-10469.
    PubMed         Abstract available

  13. GOLDBACH MM, Burkbauer L, Bharani T, Williams AD, et al
    Correction to: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer-An NCDB Analysis (2004-2016).
    Ann Surg Oncol. 2021 Jul 15. pii: 10.1245/s10434-021-10403.
    PubMed        

  14. CHAGPAR AB, Berger E, Alperovich M, Zanieski G, et al
    Assessing Interobserver Variability of Cosmetic Outcome Assessment in Breast Cancer Patients Undergoing Breast-Conservation Surgery.
    Ann Surg Oncol. 2021 Jul 15. pii: 10.1245/s10434-021-10442.
    PubMed         Abstract available

  15. HOFFMAN DI, Santos PMG, Goldbach M, Keele LJ, et al
    Immediate Breast Reconstruction for Inflammatory Breast Cancer: Trends in Use and Clinical Outcomes 2004-2016.
    Ann Surg Oncol. 2021 Jul 16. pii: 10.1245/s10434-021-10404.
    PubMed         Abstract available

  16. WILLIAMS AD, Ciocca R, Sabol JL, Carp NZ, et al
    Institutions Treating Breast Cancer Patients of a Low Socioeconomic Status Achieve Multidisciplinary Quality Standards at Lower Rates.
    Ann Surg Oncol. 2021 Jul 16. pii: 10.1245/s10434-021-10451.
    PubMed         Abstract available

  17. HOFFMAN DI, Santos PMG, Goldbach M, Keele LJ, et al
    ASO Visual Abstract: Immediate Breast Reconstruction for Inflammatory Breast Cancer-Trends in Use and Clinical Outcomes, 2004-2016.
    Ann Surg Oncol. 2021 Jul 16. pii: 10.1245/s10434-021-10475.
    PubMed        


    BMC Cancer

  18. LI S, Wu J, Huang O, He J, et al
    Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2- patients.
    BMC Cancer. 2021;21:807.
    PubMed         Abstract available

  19. SONG D, Hu Y, Diao B, Miao R, et al
    Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast Cancer.
    BMC Cancer. 2021;21:798.
    PubMed         Abstract available

  20. VIALA M, Firmin N, Touraine C, Pouderoux S, et al
    Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer.
    BMC Cancer. 2021;21:815.
    PubMed         Abstract available


    Br J Cancer

  21. JOHNSON N, Maguire S, Morra A, Kapoor PM, et al
    CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
    Br J Cancer. 2021;124:842-854.
    PubMed         Abstract available

  22. MARONI R, Massat NJ, Parmar D, Dibden A, et al
    A case-control study to evaluate the impact of the breast screening programme on mortality in England.
    Br J Cancer. 2021;124:736-743.
    PubMed         Abstract available


    Breast Cancer

  23. GASTERATOS K, Morsi-Yeroyannis A, Vlachopoulos NC, Spyropoulou GA, et al
    Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes.
    Breast Cancer. 2021 Jul 12. pii: 10.1007/s12282-021-01274.
    PubMed         Abstract available


    Breast Cancer (Auckl)

  24. ULLAH Z, Khan MN, Din ZU, Afaq S, et al
    Breast Cancer Awareness and Associated Factors Amongst Women in Peshawar, Pakistan: A Cross-Sectional Study.
    Breast Cancer (Auckl). 2021;15:11782234211025346.
    PubMed         Abstract available


    Breast Cancer (Dove Med Press)

  25. KANZAKI H, Chatterjee A, Hossein Nejad Ariani H, Zhang X, et al
    Disabling the Nuclear Translocalization of RelA/NF-kappaB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth.
    Breast Cancer (Dove Med Press). 2021;13:419-430.
    PubMed         Abstract available

  26. EL-BELTAGY AEBM, Elsyyad HIH, Abdelaziz KK, Madany AS, et al
    Therapeutic Role of Annona muricata Fruit and Bee Venom Against MNU-Induced Breast Cancer in Pregnant Rats and its Complications on the Ovaries.
    Breast Cancer (Dove Med Press). 2021;13:431-445.
    PubMed         Abstract available


    Breast Cancer Res

  27. OTTOLINO-PERRY K, Shahid A, DeLuca S, Son V, et al
    Intraoperative fluorescence imaging with aminolevulinic acid detects grossly occult breast cancer: a phase II randomized controlled trial.
    Breast Cancer Res. 2021;23:72.
    PubMed         Abstract available


    Breast Cancer Res Treat

  28. TANG A, Cohan CM, Hansen KS, Beattie G, et al
    Relationship between body mass index and malignancy rates of MRI-guided breast biopsies: impact of clinicodemographic factors.
    Breast Cancer Res Treat. 2021;188:739-747.
    PubMed         Abstract available

  29. WEITZEL JN, Kidd J, Bernhisel R, Shehayeb S, et al
    Multigene assessment of genetic risk for women for two or more breast cancers.
    Breast Cancer Res Treat. 2021;188:759-768.
    PubMed         Abstract available

  30. SATO S, Maki S, Yamanaka T, Hoshino D, et al
    Machine learning-based image analysis for accelerating the diagnosis of complicated preneoplastic and neoplastic ductal lesions in breast biopsy tissues.
    Breast Cancer Res Treat. 2021;188:649-659.
    PubMed         Abstract available

  31. LAISH I, Friedman E, Levi-Reznick G, Kedar I, et al
    Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications.
    Breast Cancer Res Treat. 2021;188:685-694.
    PubMed         Abstract available

  32. COUGHLIN SS, Ayyala DN
    Symptoms associated with comorbid diabetes among breast cancer survivors.
    Breast Cancer Res Treat. 2021 Jul 9. pii: 10.1007/s10549-021-06324.
    PubMed         Abstract available

  33. WALBAUM B, Puschel K, Medina L, Merino T, et al
    Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients.
    Breast Cancer Res Treat. 2021 Jul 10. pii: 10.1007/s10549-021-06317.
    PubMed         Abstract available

  34. DENT R, Oliveira M, Isakoff SJ, Im SA, et al
    Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer.
    Breast Cancer Res Treat. 2021 Jul 15. pii: 10.1007/s10549-021-06143.
    PubMed         Abstract available

  35. BOTTY VAN DEN BRUELE A, Ferraro E, Sevilimedu V, Hogan MP, et al
    Does preoperative MRI accurately stratify early-stage HER2 + breast cancer patients to upfront surgery vs neoadjuvant chemotherapy?
    Breast Cancer Res Treat. 2021 Jul 14. pii: 10.1007/s10549-021-06331.
    PubMed         Abstract available

  36. BEKELE BM, Luijendijk M, Schagen SB, de Ruiter M, et al
    Fatigue and resting-state functional brain networks in breast cancer patients treated with chemotherapy.
    Breast Cancer Res Treat. 2021 Jul 14. pii: 10.1007/s10549-021-06326.
    PubMed         Abstract available


    Cancer

  37. FAN Q, Yao XA, Han X
    Spatial variation and disparity in female breast cancer relative survival in the United States.
    Cancer. 2021 Jul 15. doi: 10.1002/cncr.33801.
    PubMed         Abstract available

  38. PRINTZ C
    Mindfulness meditation helps younger breast cancer survivors.
    Cancer. 2021;127:2607.
    PubMed        


    Cancer Cell

  39. PEREZ-GARCIA J, Gion M, Cortes J
    I-SPY2 platform: New lessons from the olaparib and durvalumab combination in breast cancer treatment.
    Cancer Cell. 2021;39:902-904.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  40. ANDERSSON EM, Sandsveden M, Forsgard N, Sallsten G, et al
    Is cadmium a risk factor for breast cancer - results from a nested case-control study using data from the Malmo Diet and Cancer Study.
    Cancer Epidemiol Biomarkers Prev. 2021 Jul 8. pii: 1055-9965.EPI-21-0181.
    PubMed         Abstract available


    Cancer Lett

  41. XU X, Li N, Wang Y, Yu J, et al
    Calcium channel TRPV6 promotes breast cancer metastasis by NFATC2IP.
    Cancer Lett. 2021;519:150-160.
    PubMed         Abstract available


    Cancer Res

  42. GOMEZ TEJEDA ZANUDO J, Mao P, Alcon C, Kowalski K, et al
    Cell line-specific network models of ER+ breast cancer identify potential PI3Kalpha inhibitor resistance mechanisms and drug combinations.
    Cancer Res. 2021 Jul 13. pii: 0008-5472.CAN-21-1208.
    PubMed         Abstract available


    Clin Breast Cancer

  43. CHEN M, Wu J, Liu D, Chen W, et al
    Combined Estrogen Receptor and Progesterone Receptor Level Can Predict Survival Outcome in Human Epidermal Growth Factor Receptor 2-positive Early Breast Cancer.
    Clin Breast Cancer. 2021 Jun 16. pii: S1526-8209(21)00140.
    PubMed         Abstract available

  44. TOKUI R, Ishitobi M, Kurita T, Hatano T, et al
    A Comparison of the Oncological Outcomes After Breast-Conserving Surgery With or Without Latissimus Dorsi Myocutaneous Flap Reconstruction for Breast Cancer.
    Clin Breast Cancer. 2021 Jun 15. pii: S1526-8209(21)00150.
    PubMed         Abstract available

  45. CERNUSCO NLV, Bianco PD, Romano M, Muraglia A, et al
    Long-Term Outcomes Using Electron IOERT APBI for Early Stage Breast Cancer: The Verona University Hospital Experience.
    Clin Breast Cancer. 2021 Jun 10. pii: S1526-8209(21)00143.
    PubMed         Abstract available


    Clin Cancer Res

  46. YAM C, Yen EY, Chang JT, Bassett RL, et al
    Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.
    Clin Cancer Res. 2021 Jul 12. pii: 1078-0432.CCR-21-0144.
    PubMed         Abstract available


    Eur J Cancer

  47. HARTKOPF AD, Brucker SY, Taran FA, Harbeck N, et al
    Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis.
    Eur J Cancer. 2021;154:128-137.
    PubMed         Abstract available


    Eur Radiol

  48. RAHBAR H, Tjoe JA
    Breast MRI in the setting of DCIS: quality trials are still needed to determine its value.
    Eur Radiol. 2021;31:5877-5879.
    PubMed         Abstract available

  49. POTSCH N, Dietzel M, Kapetas P, Clauser P, et al
    An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies.
    Eur Radiol. 2021;31:5866-5876.
    PubMed         Abstract available

  50. LANG K, Hofvind S, Rodriguez-Ruiz A, Andersson I, et al
    Can artificial intelligence reduce the interval cancer rate in mammography screening?
    Eur Radiol. 2021;31:5940-5947.
    PubMed         Abstract available

  51. DE MARGERIE-MELLON C, Debry JB, Dupont A, Cuvier C, et al
    Nonpalpable breast lesions: impact of a second-opinion review at a breast unit on BI-RADS classification.
    Eur Radiol. 2021;31:5913-5923.
    PubMed         Abstract available


    Int J Cancer

  52. JANSANA A, Poblador-Plou B, Gimeno-Miguel A, Lanzuela M, et al
    Multimorbidity clusters among long-term breast cancer survivors in Spain: Results of the SURBCAN Study.
    Int J Cancer. 2021 Jul 13. doi: 10.1002/ijc.33736.
    PubMed         Abstract available


    J Natl Cancer Inst

  53. ALAGOZ O, Lowry KP, Kurian AW, Mandelblatt JS, et al
    Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.
    J Natl Cancer Inst. 2021 Jul 14. pii: 6319940. doi: 10.1093.
    PubMed         Abstract available

  54. SEMBA T, Wang X, Xie X, Cohen EN, et al
    Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated with an Immunosuppressive Tumor Microenvironment.
    J Natl Cancer Inst. 2021 Jul 12. pii: 6313157. doi: 10.1093.
    PubMed         Abstract available


    Lancet Oncol

  55. DENKERT C, Seither F, Schneeweiss A, Link T, et al
    Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
    Lancet Oncol. 2021 Jul 9. pii: S1470-2045(21)00301.
    PubMed         Abstract available


    N Engl J Med

  56. GANGULY S, Gogia A
    Sacituzumab Govitecan in Metastatic Breast Cancer.
    N Engl J Med. 2021;385:e12.
    PubMed        

  57. BARDIA A, Hurvitz SA, Rugo HS
    Sacituzumab Govitecan in Metastatic Breast Cancer. Reply.
    N Engl J Med. 2021;385:e12.
    PubMed        


    NPJ Breast Cancer

  58. CHEN H, Padia R, Li T, Li Y, et al
    Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1.
    NPJ Breast Cancer. 2021;7:91.
    PubMed         Abstract available

  59. CARMONA-BAYONAS A, Calderon C, Hernandez R, Fernandez Montes A, et al
    Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy.
    NPJ Breast Cancer. 2021;7:92.
    PubMed         Abstract available


    Oncogene

  60. CLEMENTS ME, Holtslander L, Edwards C, Todd V, et al
    HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer.
    Oncogene. 2021 Jul 10. pii: 10.1038/s41388-021-01931.
    PubMed         Abstract available

  61. YU P, Zhu X, Zhu JL, Han YB, et al
    The Chk2-PKM2 axis promotes metabolic control of vasculogenic mimicry formation in p53-mutated triple-negative breast cancer.
    Oncogene. 2021 Jul 9. pii: 10.1038/s41388-021-01933.
    PubMed         Abstract available


    PLoS One

  62. KENNEY J, Ndoye A, Lamar JM, DiPersio CM, et al
    Comparative use of CRISPR and RNAi to modulate integrin alpha3beta1 in triple negative breast cancer cells reveals that some pro-invasive/pro-metastatic alpha3beta1 functions are independent of global regulation of the transcriptome.
    PLoS One. 2021;16:e0254714.
    PubMed         Abstract available

  63. YANG J, Virostko J, Hormuth DA 2nd, Liu J, et al
    An experimental-mathematical approach to predict tumor cell growth as a function of glucose availability in breast cancer cell lines.
    PLoS One. 2021;16:e0240765.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  64. UPTON R, Banuelos A, Feng D, Biswas T, et al
    Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: